These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8374538)

  • 1. Recurrence of acute leukemia in donor cells after bone marrow transplantation: documentation by in situ DNA hybridization.
    Mouratidou M; Sotiropoulos D; Deremitzaki K; Spathas DH; Hoffbrand AV; Prentice HG; Papanastasiou K; Tsakanikas S; Tsaftaridis P; Stamatelou M
    Bone Marrow Transplant; 1993 Jul; 12(1):77-80. PubMed ID: 8374538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synchronous development of acute myeloid leukemia in recipient and donor after allogeneic bone marrow transplantation: report of a case with comments on donor evaluation.
    Glasser L; Meloni-Ehrig A; Greaves W; Demel KC; Butera J
    Transfusion; 2009 Mar; 49(3):555-62. PubMed ID: 19040490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
    Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
    Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute myeloid leukemia of donor origin after allogeneic bone marrow transplantation for precursor T-cell acute lymphoblastic leukemia: case report and review of the literature.
    Reichard KK; Zhang QY; Sanchez L; Hozier J; Viswanatha D; Foucar K
    Am J Hematol; 2006 Mar; 81(3):178-85. PubMed ID: 16493618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Need for an accurate molecular diagnosis to assess the donor origin of leukemia relapse after allogeneic stem cell transplantation.
    Spinelli O; Giussani U; Borleri G; Lazzari M; Michelato A; Dotti G; Barbui T; Rambaldi A
    Haematologica; 2000 Nov; 85(11):1153-7. PubMed ID: 11064467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-cell lymphoma developing in the donor 9 years after donor-origin acute myeloid leukemia post bone marrow transplantation.
    Bielorai B; Deeg HJ; Weintraub M; Neumann Y; Rosner E; Amariglio N; Rechavi G; Toren A
    Bone Marrow Transplant; 2003 May; 31(10):931-4. PubMed ID: 12748672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In situ hybridization using a Y-specific probe--a sensitive method for distinguishing residual male recipient cells from female donor cells in bone marrow transplantation.
    Wessman M; Ruutu T; Volin L; Knuutila S
    Bone Marrow Transplant; 1989 May; 4(3):283-6. PubMed ID: 2659113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT.
    Bader P; Beck J; Frey A; Schlegel PG; Hebarth H; Handgretinger R; Einsele H; Niemeyer C; Benda N; Faul C; Kanz L; Niethammer D; Klingebiel T
    Bone Marrow Transplant; 1998 Mar; 21(5):487-95. PubMed ID: 9535041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia.
    Zetterquist H; Mattsson J; Uzunel M; Näsman-Björk I; Svenberg P; Tammik L; Bayat G; Winiarski J; Ringdén O
    Bone Marrow Transplant; 2000 Apr; 25(8):843-51. PubMed ID: 10808205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Is leukemic transformation of donor cells possible?].
    Vinogradova OA; Savchenko VG; Domracheva EV; Parovichnikova EN; Diachenko LV; Alimova GA; Mendeleeva LP; Liubimova LS; Sokolov AN; Zhelnova EI; Pokrovskaia OS
    Ter Arkh; 2004; 76(7):28-34. PubMed ID: 15379124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune evasion strategies of pediatric precursor-B acute lymphoblastic leukemia after allogeneic bone marrow transplantation-a case study.
    Barbaric D; Wynne K; Aslanian S; Bond M; Reid GS
    Leuk Res; 2005 Jun; 29(6):711-4. PubMed ID: 15863213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Unrelated donor allogenetic marrow transplantation in treatment of acute and chronic leukemia].
    Huang H; Lin M; Meng H
    Zhonghua Yi Xue Za Zhi; 2001 Mar; 81(5):263-7. PubMed ID: 11798883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
    Kögler G; Hernandez A; Heyll A; Wolf HH; Wernet P
    Cancer Detect Prev; 1996; 20(6):601-9. PubMed ID: 8939346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
    Hambach L; Eder M; Dammann E; Battmer K; Stucki A; Heil G; Ganser A; Hertenstein B
    Bone Marrow Transplant; 2001 Oct; 28(7):705-7. PubMed ID: 11704795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor cell leukemia in a patient developing 11 months after an allogeneic bone marrow transplantation for chronic myeloid leukemia.
    Ataergin S; Arpaci F; Cetin T; Guran S; Yakicier C; Beyzadeoglu M; Ozet A
    Am J Hematol; 2006 May; 81(5):370-3. PubMed ID: 16628734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of the time course of mixed chimerism by fluorescent in situ hybridization in patients with chronic myeloid leukemia after allogenic transplantation of bone marrow].
    Vinogradova OA; Savchenko VG; Neverova AL; Diachenko LV; Domracheva EV; Liubimova LS; Mendeleeva LP
    Ter Arkh; 2001; 73(7):26-34. PubMed ID: 11523405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor lymphocyte infusion induced molecular remission in relapse of acute myeloid leukaemia after allogeneic bone marrow transplantation.
    Au WY; Lie AK; Lee CK; Liang R; Kwong YL
    Bone Marrow Transplant; 1999 Jun; 23(11):1201-3. PubMed ID: 10382962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of residual host cells after bone marrow transplantation using non-isotopic in situ hybridization and karyotype analysis.
    Wessman M; Popp S; Ruutu T; Volin L; Cremer T; Knuutila S
    Bone Marrow Transplant; 1993 Apr; 11(4):279-84. PubMed ID: 8485475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.
    Naparstek E; Nagler A; Or R; Kapelushnik J; Slavin S
    Clin Transpl; 1996; ():281-90. PubMed ID: 9286578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Philadelphia chromosome positive acute lymphoblastic leukemia of donor origin after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase.
    Saito Y; Uzuka Y; Sakai N; Suzuki S; Toyota T
    Bone Marrow Transplant; 2000 Jun; 25(11):1209-11. PubMed ID: 10849535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.